NCT02486198 Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer Status COMPLETED Phase PHASE3
NCT01982591 Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy Status COMPLETED Phase N/A
NCT01978743 Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen Status COMPLETED Phase NA
NCT01499940 Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway Status TERMINATED Phase PHASE2
NCT01417507 Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Status COMPLETED Phase N/A
NCT01399372 Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Status COMPLETED Phase PHASE2
NCT01381718 Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Status COMPLETED Phase PHASE2
NCT01372774 Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery Status COMPLETED Phase PHASE3
NCT01293851 Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage Status TERMINATED Phase N/A
NCT01279681 Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE3
NCT01196442 Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer Status COMPLETED Phase NA
NCT01099449 Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Status COMPLETED Phase PHASE3
NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00952848 Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy Status COMPLETED Phase PHASE2
NCT00884767 Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin Status UNKNOWN Phase PHASE2
NCT00834496 Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation Status WITHDRAWN Phase N/A
NCT00792142 Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00775645 S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo Status COMPLETED Phase PHASE3